Diabetic Retinopathy Screening Adherence
Romanian Journal of Ophthalmology · 15.12.2024 · 68 (4)
DOI: 10.22336/rjo.2024.76 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Romanian Journal of Ophthalmology, online erschienen am 29.12.2024. Verfasst von Pasha Anvari und 7 weiteren Autor:innen. Beteiligte Einrichtung: Eye Research Center, The Five Senses Health Institute, Rassoul Akram Hospital, Iran; University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Mass Screening, Patient Compliance. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Eye Research Center, The Five Senses Health Institute, Rassoul Akram Hospital, Iran; University of Medical Sciences, Tehran, Iran.
- Department of Ophthalmology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
- School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
- Stem Cell and Regenerative Medicine Research Center, Iran University of Medical Sciences, Tehran, Iran.
Zitieren
APA
Anvari, P., Mirshahi, R., Nezhad, F. H., Birjandi, A. H., Daneshvar, K., Fakhar, R., Ghomashi, A., & Falavarjani, K. G. (2024). Diabetic Retinopathy Screening Adherence. Romanian Journal of Ophthalmology, 68(4). https://doi.org/10.22336/rjo.2024.76
Vancouver
Anvari P, Mirshahi R, Nezhad FH, Birjandi AH, Daneshvar K, Fakhar R, et al. Diabetic Retinopathy Screening Adherence. Romanian Journal of Ophthalmology. 2024;68(4). doi:10.22336/rjo.2024.76
BibTeX
@article{Anvari2024,
author = {Anvari, Pasha and Mirshahi, Reza and Nezhad, Faezeh Hashemi and Birjandi, Alireza Helal and Daneshvar, Kimia and Fakhar, Ramin and Ghomashi, Atefeh and Falavarjani, Khalil Ghasemi},
title = {Diabetic Retinopathy Screening Adherence},
journal = {Romanian Journal of Ophthalmology},
year = {2024},
volume = {68},
number = {4},
doi = {10.22336/rjo.2024.76}
}
EUVIMED